MT
EW icon

Midwest Trust’s Edwards Lifesciences EW Stock Holding History

Midwest Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Sell
3,144
-224
-7% -$18.5K ﹤0.01% 543
2025
Q4 		$287K Sell
3,368
-14
-0.4% -$1.15K ﹤0.01% 517
2025
Q3 		$263K Buy
3,382
+14
+0.4% +$1.09K ﹤0.01% 530
2025
Q2 		$263K Buy
+3,368
New +$251K ﹤0.01% 540

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Midwest Trust's EW Position: Q1 2026 in Review

Midwest Trust reduced its Edwards Lifesciences (EW) stake by 6.7% in Q1 2026, selling an estimated $18.5K and leaving 3,144 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Midwest Trust first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $287K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Midwest Trust held 3,144 shares of Edwards Lifesciences worth $252K as of Q1 2026.
  • Midwest Trust sold 224 Edwards Lifesciences shares in Q1 2026, an estimated $18.5K.
  • Edwards Lifesciences made up ﹤0.01% of Midwest Trust's portfolio in Q1 2026, its #543 holding.
  • Midwest Trust first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • Midwest Trust's Edwards Lifesciences position peaked at $287K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.